# The Impact of Opioid and Cannabis Exposure on Fetal Growth

> **NCT05899101** · — · TERMINATED · sponsor: **Dr. Laura Gaudet** · enrollment: 20 (actual)

## Conditions studied

- Pregnancy Related
- Substance Use
- Fetal Growth Retardation
- Placenta Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05899101
- **Lead sponsor:** Dr. Laura Gaudet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-23
- **Primary completion:** 2024-10-15
- **Final completion:** 2024-11-30
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Due to challenges with participant recruitment the propsective study was terminated.
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05899101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05899101, "The Impact of Opioid and Cannabis Exposure on Fetal Growth". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05899101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*